A Study of Adavosertib (MK-1775) in Combination With Topotecan/Cisplatin in Participants With Cervical Cancer (MK-1775-008)

PHASE1,PHASE2

Phase

TERMINATED

Status

Enrollment

INDUSTRY

Sponsor class

Stopped The sponsor permanently suspended new enrollment into the trial and discontinued the study; which was not related to any concerns over product safety.

Conditions

Cervical Cancer

Interventions

DRUG: adavosertib
DRUG: Topotecan
DRUG: Cisplatin
DRUG: Placebo to adavosertib

Sponsor

Merck Sharp & Dohme LLC